|
|
|
 |
|
|
Clinical Trial News
|
|
|
|
|
ALS TDI and NEALS to Launch Phase II Trial of TDI 132
February 14th, 2012
TDI 132, also known as Gilenya®, will be investigated for safety and tolerability in patients with ALS. Learn more.
Brainstorm Announces Safety of NurOwn™Treatment
January 17th, 2012
No significant side effects noted in initial Brainstorm participants. Read the Press Release.
Positive Preliminary Results Released by Phytopharm
January 16th, 2012
Cogane has demonstrated efficacy in genetic preclinical model of ALS. Read more.
Biomarkers Study Looking for Participants
January 13th, 2012
Researchers hope to learn more about ALS through patient samples. Read how you can help.
ALS/MND's "Ask the Experts" Forum is Available Online
December 22nd, 2011
Watch the November 28th streamed "Ask the Experts" forum from Sydney, Australia in case you missed it. Learn more.
Results from Phase III Trophos Trial Released
December 14th, 2011
Trophos, a French pharmaceutical company, announced results from its phase III trial of Olesoxime. Read more.
Knopp Announces Positive Phase II Results
November 21st, 2011
Phase II Dexpramipexole, funded by Knopp, shown to be safe and tolerable in patients with ALS. Read the Press Release.
First Annual NEALS Clinical Research Learning Institute Held
November 16th, 2011
NEALS held a meeting in Clearwater, FL for patients and their caregivers to become ALS advocates. Read more.
Ceftriaxone, NP001, and Dexpramipexole Trials Close Enrollment
November 15th, 2011
Phase III trial of Ceftriaxone; Neuraltus, the Phase II study of NP001 in ALS; and EMPOWER, the Phase III study of Dexpramipexole in ALS, are no longer recruiting participants. Read more.
Recipients of NEALS Funding Announced
November 2nd, 2011
The Neurology Clinical Trial Unit at Massachusetts General Hospital and NEALS announced a call for trial applications for high-potential treatments for ALS. Read more.
Alzforum news series about NEALS
November 2nd, 2011
NEALS is in the news! We are excited to announce that the Alzheimer's Research Forum has put together a series of four stories focused on the NEALS Consortium. Read the article.
Most Common Genetic Cause of ALS Discovered
September 30, 2011
Steve Han MD, PhD discusses newly discovered information regarding chromosome 9p21. Read more.
Researchers Discover Common Cause of ALS
August 22nd, 2011
Researchers at Northwestern discovered a new gene linked to familial ALS involved in the processing of accumulated proteins. Read more.
ALS Trial Expert Available to Answer Questions
August 12th, 2011
NEALS and the ALS Association launch a new effort to better provide accurate information about clinical trials. An "Expert" is immediately available help people navigate through clinical research information. Read more.
|
|
